Sponsor:
University of British Columbia
Code:
NCT00414115
Conditions
Adverse Drug Reaction (ADR)
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Adverse Drug Reaction (ADR)
Study ID
NCT00414115
Start date
Aug, 2005
Status verified date
Apr, 2026
Completion date
Mar, 2029
Anticipated
Primary completion date
Mar, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
7000 participants
Anticipated
Primary outcome measure
Central contacts
Locations
Children's and Women's Health Centre of British Columbia
Recruiting
Vancouver, British Columbia, Canada, V6H 3V4
Contacts
Principal Investigator:
Bruce Carleton, MD
Sponsor
University of British Columbia
Last update posted
May 1, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of British Columbia on 2026-05-01.